Unknown NA INTERVENTIONAL 2-arm NCT05161039

Serranator Recoil Study

Recoil Feasibility Study for the Treatment of Atherosclerotic Lesions in the Infrapopliteal Arteries Comparing Serration Angioplasty (Serranator® Device) vs. Plain Balloon Angioplasty (POBA)

Sponsor: Cagent Vascular LLC

Conditions Critical Limb Ischemia Peripheral Arterial Disease

Interventions POBA Serranator

Updated 4 times since 2022 Last updated: Jun 7, 2022 Started: Nov 15, 2021 Primary completion: Jul 31, 2022 Completion: Jul 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Critical Limb Ischemia and Peripheral Arterial Disease, this trial is ongoing. The trial is conducted by Cagent Vascular LLC and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Recruiting → Unknown
Jul 2022 — Jul 2024 [monthly]

Recruiting NA
Jan 2022 — Jul 2022 [monthly]

Recruiting NA

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cagent Vascular LLC

Data source: Cagent Vascular LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Arnsberg, Germany
• Palo Alto, United States